161 related articles for article (PubMed ID: 3527412)
1. Concomitant illness in patients treated for Hodgkin's disease.
Bookman MA; Longo DL
Cancer Treat Rev; 1986 Jun; 13(2):77-111. PubMed ID: 3527412
[No Abstract] [Full Text] [Related]
2. Nonmalignant complications of therapy for Hodgkin's disease.
Hohl RJ; Schilsky RL
Hematol Oncol Clin North Am; 1989 Jun; 3(2):331-43. PubMed ID: 2663831
[TBL] [Abstract][Full Text] [Related]
3. Late complications of Hodgkin's disease management.
Young RC; Bookman MA; Longo DL
J Natl Cancer Inst Monogr; 1990; (10):55-60. PubMed ID: 2189477
[TBL] [Abstract][Full Text] [Related]
4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
5. Treatment-related morbidity in patients with lymphoma.
Hubbard SM; Longo DL
Curr Opin Oncol; 1991 Oct; 3(5):852-62. PubMed ID: 1751579
[TBL] [Abstract][Full Text] [Related]
6. [Second tumors following treatment of Hodgkin's disease].
Somers R; van Leeuwen FE; Taal BG; van Heerde P; Coster B; Hart AA
Ned Tijdschr Geneeskd; 1988 Jul; 132(29):1358-62. PubMed ID: 3412505
[No Abstract] [Full Text] [Related]
7. [Incidence and significance of therapy-associated late toxicity in Hodgkin's disease].
Streit M; Thiel E; Kreuser ED
Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1093-9. PubMed ID: 7641593
[No Abstract] [Full Text] [Related]
8. Leukemia following Hodgkin's disease.
Kaldor JM; Day NE; Clarke EA; Van Leeuwen FE; Henry-Amar M; Fiorentino MV; Bell J; Pedersen D; Band P; Assouline D
N Engl J Med; 1990 Jan; 322(1):7-13. PubMed ID: 2403650
[TBL] [Abstract][Full Text] [Related]
9. Second neoplasms in Hodgkin's disease: current controversies.
Zarrabi MH; Rosner F
Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin's disease: long-term effects of therapy.
Rowland KM; Murthy A
Med Pediatr Oncol; 1986; 14(2):88-96. PubMed ID: 3520268
[No Abstract] [Full Text] [Related]
11. Hodgkin's disease in children.
Pao WJ; Kun LE
Hematol Oncol Clin North Am; 1989 Jun; 3(2):345-65. PubMed ID: 2663832
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's disease. Treatment sequelae and quality of life.
Henry-Amar M
Baillieres Clin Haematol; 1996 Sep; 9(3):595-618. PubMed ID: 8922248
[TBL] [Abstract][Full Text] [Related]
13. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's disease: controversies and challenges for the future.
Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani PL
Haematologica; 1991; 76(4):263-79. PubMed ID: 1724436
[No Abstract] [Full Text] [Related]
15. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
[TBL] [Abstract][Full Text] [Related]
16. Secondary leukemia following treatment for Hodgkin's disease.
Salvagno L; Simonato L; Sorarù M; Bianco A; Chiarion-Sileni V; Aversa SM; Camporese R; Garofolin P; Fiorentino M
Tumori; 1993 Apr; 79(2):103-7. PubMed ID: 8346559
[TBL] [Abstract][Full Text] [Related]
17. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
Tester WJ; Kinsella TJ; Waller B; Makuch RW; Kelley PA; Glatstein E; DeVita VT
J Clin Oncol; 1984 Jul; 2(7):762-9. PubMed ID: 6547479
[TBL] [Abstract][Full Text] [Related]
18. Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
Jacquillat C; Khayat D; Desprez-Curely JP; Weil M; Brocheriou C; Auclerc G; Chamseddine N; Bernard J
Cancer; 1984 Feb; 53(3):459-62. PubMed ID: 6362816
[TBL] [Abstract][Full Text] [Related]
19. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
Blayney DW; Longo DL; Young RC; Greene MH; Hubbard SM; Postal MG; Duffey PL; DeVita VT
N Engl J Med; 1987 Mar; 316(12):710-4. PubMed ID: 3821809
[TBL] [Abstract][Full Text] [Related]
20. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
